Novotech Releases Latest Snapshot of Australian Clinical Trials Activity
The latest Novotech snapshot of Australian #clinicaltrial activity has been released. It indicates there’s upwards of an 80% return to business across some of our highest performing sites. Other key items to note are a broadly accepted use of #eSignature, a reduced impact on #IMP dispensing,and improved #HREC and #RGO timelines. Does this reflect your […]